Leading innovative devices for acoustic
cell processing
We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
Trusted by
Aenitis Technologies aims to become a world leader in cells handling solutions by acoustophoresis.
Who we are
Cell Therapy: The New Biotech Gold Rush
Aenitis Technologies is a French spin off ESPCI ParisTech, a research engineer’s school in Paris and The National Center for Scientific Research (CNRS).

Aenitis Technologies is developing innovative separation, manipulation and filtration of biological elements solutions, based on acoustophoresis technologies.

Our first focuse is on technological solutions that will revolutionize current practices in Public Health by improving bioproduction processing in cell therapy areas
2014
Year founded
9M€
Money Raised
13
Patents families
How did we started?
Aenitis' Journey
Since 2015
2015
€1.7M Raised
French Ministry of Research and Paris Region mail innovation concourses awards - €700k grants

Seventure Partners - €1M Capital Increase
End: 6m before deadline
2017
€4M Raised
Lab prototype on Labile blood product validated on human blood

Platelets journal publication: world first on platelets processing without activation

H2020 European Commission program recognition
End: 6m before deadline
2018
€2.1M Raised
1st acoustofluidic disposable injected alpha prototypes delivered

1st device - machine - alpha prototype delivered

Weaving Invest & Seventure Partners - €1M capital increase

France Innovation Concours winner on Islets acoustic sorting - €1.1M grants

Winner of European Commission EIT Health MedTech Catapult concours
End: 6m before deadline
2019
€1M Raised
End of feasibility for the acoustic platelets processing. Launch of the industrialization.

€1M grant on Mesenchymal Stem Cell Acoustic Sorter, supported by the French Ministry of Economic and the French Ministry of the Army.

Key Partnership with a large corporate
End: 6m before deadline
2020
€3M Fundraising planned
Acoustic Blood Cell Sorter industrialisation launched

€0.5M grant acoustic Transduction and transfection boost system, supported by Paris Region.

ISO 13485 engaged

ISO 9001 engaged
End: 6m before deadline
2022 / 2024 Vision
Our aim is to become a world leader in cell therapy processing devices solutions based on acoustophoresis.
$19.9Bn
is the Global cell therapy processing devices market
expected for 2023 according to (MarketsAndMarkets)
CAGR 14,4%
Aenitis' acoustophoretic approach enable to simplify Bioprocess in cell therapies, aiming:

- yield increase,
- more secure processing,
- lower cost processing ,
- and higher cell quality.

Today, for example, Aenitis' approach permits on platelet processing to gain, compared to current standards, 15% on platelets recovery, 20% on the processing timing, reduce handling contain and reduce costs. Platelets are also not activated by acoustic handling that permit optimal quality to be maintained.
Our team
Our strenght is in our team

After obtaining a Master in Cellular and Molecular Biology from the University of Nantes (FR) and the University of Sussex (UK), Emmanuel completed his training with a Specialized Master in Management of Biotechnology Companies in Grenoble Ecole de Management (Grenoble Business School). He also holds an Executive Master of Business and Administration (eMBA) from the University Paris-Dauphine (FR) and the University of Quebec in Montreal (CA). Emmanuel has a strong professional experience in international business development, in analysis of business models and in consolidation of strategic intelligence in the biotechnology sector. He also has a good knowledge of the biotech ecosystem in France, and of the major world bioclusters.

Emmanuel VINCENT
Co-founder and Chief Executive Officer
Linkedin

Jacky holds a degree of the DESF (Graduate degree in accounting and financial studies) and began his career in an audit and financial expertise firm during 4 years. For nearly 20 years, Jacky holds positions in Finance (CFO) and General Management (COO/CEO) in companies with high development potential (Startups).
The quality of the relations that Jacky has forged with his investors, led him in addition to advising them to regularly represent them on the management and/or strategic committees of other companies that they finance.
His experience and analytical skills allow him to combine the management of day-to-day imperatives with the medium- and long-term objectives of a company with high development potential.

Jacky HARROUET
Chief Financial Officer
Linkedin

Fabrice holds a PhD degree inphysics, (IEF, Paris, 2001) and a management degree (HEC, Paris, 2013).After joining Philips Semiconductors as Design and Technology Manager, Fabricedeveloped MEMS for biomedical application. Then, Fabrice holds severalmanagement positions (Innovation, R&D) as CTO and CEO in medical devicescompanies in physiological monitoring, in eye-tracking and in ophthalmologyfields. He launched Class IIa and Class IIB medical devices on themarket. 

Fabrice VERJUS
Chef Technology and Regulatory Officer, PhD
Linkedin

Coming from the field of Applied Physics, Jérémie Gachelin holds a Master’s degree in Complex Systems (Denis Diderot University, Paris). After a PhD in Physics, he worked for three years in the PMMH laboratory in Paris and the Departemento de Physica at the Universidad de Chile on an experimental and digital study of the interactions between micro-swimmers (i.e. E. Coli bacteria). This study included the analysis from a physicist point of view of the effects of the presence of a surrounding flow using microfluidic devices. Jérémie has therefore developed expertise in microfluidics, microbiology, and digital simulations for applications in physics.

Jérémie GACHELIN
Biophysics Engineer - PhD
Linkedin

Louisis a highly versatile R&D engineer passionate about bringing the latestscientific innovations to the medical field.  Hegraduated from Ecole polytechnique and holds a Master’s of Science in FluidMechanics from UC Berkeley.  Louisthen spent four years in the Silicon Valley where he successfully developed andbrought to market a patented at-home blood testing device.

Louis VIREY
Development Engineer
Linkedin

Côme holds an engineering degree in general engineering with a specialization in biomechanics and biomedical (at EPF, Sceaux). He joins the team as a research engineer to work on the prototype and solution design. He works on numerical simulations around the prototype and on all the physics involved to understand and explain how the device works.

Côme TRESCA
Biomechanics Engineer 
Linkedin

Nicolas earned both a master's and PhD degree from the University of Bordeaux, France in acoustics, laser, and fluid mechanics, more specifically working on the effects of radiation pressure on liquid interfaces. He designed experiments as well as developed a new theory on the self-guiding of acoustic waves in liquids. He then joined the Complex Fluids team at the University of Melbourne, Australia for a post-doctoral fellowship on polymers and particles in shear-flow, broadening his skills in experimental soft matter and 3D printing. 2 years later, he joined the BubbleBoost project at the Laboratoire Interdisciplinaire de Physique in Grenoble, France, working for 3 years on generating flows with acoustically-driven microbubbles. This project made use of his expertise in acoustofluidics and 3D printing, applying them to microfluidic applications. It led him to collaborate fruitfully with theorists, chemists and engineers.

Nicolas BERTIN
Biophysics Engineer - PhD
Linkedin

After finishing valedictorian of the Master in Cellular biology of Paris 7 University, Déborah worked at INSERM to pursue her thesis. She highlighted the protective role of a Serpine (Protease nexine-1) against pulmonary fibrosis by regulating coagulation and inflammation. After her PhD, she took part to a project aiming to stabilize the mutated CFTR receptor responsible for cystic fibrosis using highly specific antibodies called nanobodies, by driving the cellular biology experiments (Brussels). Déborah has a strong expertise in cellular and molecular biology.

Déborah FRANCOIS
Biology Engineer - PhD
Linkedin

Malou recently graduated in Biology Engineering from the University of Technology of Compiègne (France). During one year, she held a position of project engineer in a research institute (INEM, France) where she had in charge to study rhabdomyolysis from primary myoblasts of patients with hereditary diseases. As an engineer for Aenitis Technologies, she is part of the Biology team in which she conducts cell biology experiments.

Malou Le CORRONC
Biology Engineer - MSc
Linkedin

Xavier obtained his senior technician certificate on analysis and biological control in 2014 in ESTBA (Paris). Then he worked as a lab technician for Novalix in the Synchrotron Soleil (France) during 14 month, he was in charge of the crystallography platform and also of the microbiology platform. Afterwards, he worked as a production assistant for Theradiag (France) for 6 months, during which he managed a team of three people for the conditioning kits department.

Xavier TELOT
Engineering assistant
Linkedin

After a master's degree in 3D engineering and video games, Valentin worked in eye analysis devices and softwares for 4 years then, he joined Kickmaker where he worked on various subjects from autonomous cars to massive events like the League of legends world cup.Valentin lead softwares development at Aenitis.

Valentin HAYOT
Lead Developer full stack
Linkedin

After obtaining her state diploma in laboratory technician, Marion isachieving a Master in Management of Bioproductions at the University ofPharmacy of Tours. She joined Aenitis’ team in the regulatory affairs and qualityassurance department in 2020.

Marion PASSERA
Quality and Regulatory assistant
Linkedin

Graduate of a Master's degree in «Fluid Dynamics and Energetics» at Paris-Saclay University in 2017, Ludovic worked in the PMMH Laboratory at ESPCI - Paris on the behaviour of stem cells subjected to an acoustic field and particularly the formation of aggregates in levitation. This experience allowed him to develop a good knowledge in acoustophoresis as well as in experimental manipulation.
Today, Ludovic develops new stem cell sorting strategies.

Ludovic BELLEBON
Biophysics Engineer - PhD candidate
Linkedin

Graduated with a Master’s degree in Genetics at the Université de Paris, Hugo worked on the genetic regulation of a signaling pathway regulating the cranial development at the University of California in San Francisco (USCF, USA). He then integrated the INSERM unity of integrative biology of red blood cells (UMR_S1134, France) to study the differentiation of haematopoietic stem cells to red blood cells. His experiences allowed him to develop strong technical skills and a good knowledge in stem cells. Since the beginning of his Ph.D, Hugo has developed a new process to isolate mesenchymal stromal cells (MSCs) using acoustophoresis.

Hugo SUGIER
Biology Engineer - PhD candidate
Linkedin
-
Strategic Advisory Board

Philippe Tramoy earned degrees in Biochemistry (MSc) and Genetics & Immunology (MSc) from the University of Burgundy and from the Ecole Normale Supérieure Lyon and later graduated from the IAE Paris Pantheon-Sorbonne (Master of Finance) and HEC Paris (Master in Marketing). Philippe’s responsibilities have been wide-ranging and included being Project Manager and Business Development Manager in Europe and Israel on the biotechnology market at Rhodia Corporate, Rhodia Chirex, and Rhodia Pharma Solutions.
In 2004, he founded and managed a market and business intelligence company with offices in France, Switzerland and Israel: CBDMT – Market & Business Intelligence. During his career, Philippe developed an extensive network of contacts and core competences including business development, strategy, marketing and finance. Philippe joined Seventure in November 2013. He is a Partner at the Lifesciences investments of Quadrivium 1.

Philip TRAMOY
Strategic Board Member
Linkedin

Cofounder and previous CEO of Ovizio Imaging Systems, Philip is a success entrepreneur with good knowledge of Cell therapy markets and start-up development issues.
Passionate about science and technology, Philip holds an engineering degree in electronics and telecommunications and started his career in the high-tech sector where he held management positions for large companies in several European countries, developing strong business and commercial skills, completed by an MBA from ESCP, Paris. Throughout his career, Philip has always been driven by a will to transform his technological, market and financial knowledge in sellable and innovative products, services and solutions. After 10 years in corporate environments, Philip decided to follow the entrepreneurial path and launched his biggest professional challenges starting his first ventures.

Philip MATHUIS
Strategic Board Member
Linkedin

After graduating from the Albi Carmaux School of Mining Engineering, Idir Idjerouidene held the positions of COO and member of the board of the company Aigle Azur. Since 2011, Idir Idjerouidene is Managing Director of the Weaving Group Investment Fund.

Idir IDJEROUIDENE
Strategic Board Member
Linkedin

CNRS Research Director at the Laboratory of Physics and Mechanics of Heterogeneous Environments (PMMH), UMR7636 CNRS, and at ESPCI, Jean-Luc is a specialist in fluid mechanics and flow control. Jean-Luc worked for 7 years in the Aerodynamics research unit of the Research and Innovation Department of PSA Peugeot -Citroën as the head of a research and innovation project. He joined the CNRS in October 2005 where he developed research programs in the field of flow control, external aerodynamic instabilities, and transition to turbulence and micro-flows. Jean-Luc demonstrated the potential of the acoustic manipulation of particles for metrological applications (micro-PIV). Jean-Luc also discovered that acoustic streaming in micro-channels can be used beyond the conventional resonance condition in order to create a "sound tweezer" that enables the fine handling of species in suspension.

Jean-Luc AIDER
Co-founder, President of Scientific Advisory Board
Linkedin

After obtaining a Master in Cellular and Molecular Biology from the University of Nantes (FR) and the University of Sussex (UK), Emmanuel completed his training with a Specialized Master in Management of Biotechnology Companies in Grenoble Ecole de Management (Grenoble Business School). He also holds an Executive Master of Business and Administration (eMBA) from the University Paris-Dauphine (FR) and the University of Quebec in Montreal (CA). Emmanuel has a strong professional experience in international business development, in analysis of business models and in consolidation of strategic intelligence in the biotechnology sector. He also has a good knowledge of the biotech ecosystem in France, and of the major world bioclusters.

Emmanuel VINCENT
Strategic Board Member
Linkedin
-
Scientific Advisory Board

MiguelLozano, MD, PhD is Hematologist. He is currently Hemotherapy Section Head atthe department of Hemotherapy and Hemostasis of the Clínic University Hospital,and Associate Professor of Medicine at the University of Barcelona, inBarcelona, Spain. He is also President of the European Society forHemapheresis, European Regional Director of the ISBT Board and chair of theAABB Press Editorial Board. He has been scientific member of BEST Collaborativesince 2002.He is theauthor or co-author of over 200 papers, monographs and book chapters dealingwith topics related with Transfusion Medicine and Hemostasis. He has co-editedbooks for AABB Press about Globalization in Transfusion Medicine, BloodComponent Preparation and Platelet Transfusion Therapy.

Dr. Miquel LOZANO
Scientific Advisory Board Member
Linkedin

INSERMresearch director at the Langevin Institute ESPCI Paris, Mickaël developed withhis team new therapy techniques and medical imaging, including, for example,non-invasive treatment of brain disorders with transcranial focused ultrasound(Equipex Ultrabrain) or a new brain imaging technique: the"fUltrasound" (functional brain Ultrasound). This imaging techniquebased on the study of blood flow can detect changes in cérébrale activity. Hisworks led to the creation of a French company, Supersonic Imagine, whichmarkets a scanner that can distinguish the tissue elasticity and variations andidentify cancerous tumors. He also founded in 2015 Cardiawave that develops arevolutionary non-invasive medical device to treat a heart condition calledaortic stenosis.MickaelTanter is a member of the scientific council of the Ile de France, deputydirector of the Langevin Institute, winner of Equipex with his team. He won thegrand prize of Medical Research Jean Hamburger of the city of Paris in 2012,co-winner with Mathias Fink, Jacques Souquet and Jeremy Bercoff the Yves RocardPrize the French Society of Physics 2011, winner of the Léon Brillouin theelectricity Company, electronics and information and communications technology(EES) and the Institute of electrical and electronics Engineers (IEEE) in 2010,Montgolfier Prize winner of the Corporation encouragement for the domesticindustry in 2010.

Mickaël TANTER
Scientific Advisory Board Member
Linkedin

Chaouqi is anexceptional category CNRS research director at the Interdisciplinary Physicslaboratory of Joseph FOURNIER University in Grenoble (France). Chaouqideveloped over the year a world expertise on complex fluids with a large focuson blood in vivo and in microchannels (over 200 publications and books).

Chaouqi MISBAH
Scientific Advisory Board Member
Linkedin

CNRS Researcher at theLaboratory of Physics and Mechanics of Heterogeneous Environments (PMMH),UMR7636 CNRS, and at ESPCI, Mauricio is a specialist in dispersed colloidalenvironments, in separation sciences and in ultrasounds. Mauricio is the Winner2014 of the Henri-Langlois price for the quality of his work in the PMMHLaboratory. Mauricio worked for more than 20 years in the field of technicalseparation of polymer particles and blood cells using force fields(centrifugal, thermal and magnetic). He has been developing ultrasonicseparation technologies for biological applications for many years.

Mauricio HOYOS
Co-founder, Scientific Advisory Board Member
Linkedin

CNRS Research Director at the Laboratory of Physics and Mechanics of Heterogeneous Environments (PMMH), UMR7636 CNRS, and at ESPCI, Jean-Luc is a specialist in fluid mechanics and flow control. Jean-Luc worked for 7 years in the Aerodynamics research unit of the Research and Innovation Department of PSA Peugeot -Citroën as the head of a research and innovation project. He joined the CNRS in October 2005 where he developed research programs in the field of flow control, external aerodynamic instabilities, and transition to turbulence and micro-flows. Jean-Luc demonstrated the potential of the acoustic manipulation of particles for metrological applications (micro-PIV). Jean-Luc also discovered that acoustic streaming in micro-channels can be used beyond the conventional resonance condition in order to create a "sound tweezer" that enables the fine handling of species in suspension.

Jean-Luc AIDER
Co-founder, President of Scientific Advisory Board
Linkedin

Nobis voluptates aperiam excepturi doloribus rem unde in. Autem aspernatur veniam ab temporibus. Voluptatem odit at quaerat adipisci tenetur omnis. Eveniet qui distinctio excepturi est et necessitatibus. Qui saepe voluptas exercitationem nam quo error commodi ducimus possimu

Aut Quaerat Qui Officiis
Linkedin
Test team Member

Nemo quos suscipit. Enim nihil suscipit quisquam et et. Ipsum repellat consequatur rerum voluptatem. Ex consectetur non tempora praesentium omnis ipsam. Perspiciatis id odit doloremque. Enim tempore id cum ducimus odio dolorum accusamus dolore. Aut dolores

Dolor Eaque Sequi Nihil
Linkedin
Test team Member

Vitae reiciendis odit eum dolor. Sunt sed aperiam dicta ullam aut explicabo molestiae ut. Quaerat aliquam ad. Culpa autem modi voluptatem suscipit modi sit odit ullam adipisci. Provident sed quis quis autem ex tenetur. Ut deserunt ipsum ea ex hic. Perferendis et adipisci modi maiore

Soluta Autem
Linkedin
Test team Member

Cupiditate et quo et dolor aut assumenda possimus. Mollitia quisquam eius dolor consequuntur quia qui et et laborum. Est magni qui quisquam rem tempore. Id quae q

Architecto Vero
Linkedin
Test team Member

Nostrum non quia consequatur sunt beatae expedita eligendi fugiat qui. Officia deleniti omnis repudiandae omnis repudiandae esse dolor iure. Consectetur accusantium totam omnis itaque dolor modi odit placeat. Sunt qui reprehenderit aut accusantium quisquam assumenda. Ut eaque aut

Tempore Ut
Linkedin
Test team Member
Latest News
Be up to date with Aenitis technology
December 12, 2019
Aenitis sur le congres polepharma bioproduction 2019
Read More
November 28, 2019
"Fervently driving disruptive innovation in healthcare", Insightcare, October 2019
Read More
November 23, 2019
Eit health summit event in Paris on DEC 2ND & 3RD 2019
Read More
November 22, 2019
Bio Europe 2019 in Hamburg
Read More
November 8, 2019
Aenitis technologies on bio Europe, Hamburg, Germany
Read More
February 15, 2019
Start-up & Innovation: Aenitis Technologies Laureate Of The Ftti 2019 And Finalist Of The Evc 2019!
Read More
December 20, 2018
Second Semester Of 2018
Read More
December 19, 2018
Winner Of The Innovation Contest, Aenitis Technologies Receives 1,1m€
Read More
December 12, 2018
Aenitis technologies, laureate of the concours innovation
Read More
December 6, 2018
Aenitis technologies has been awarded the 1st prize in the European eit health catapult
Read More
November 30, 2017
Aenitis technologies receives €4 million in funding from the european H2020 sme instrument programme, for its abc-s’ project
Read More
October 19, 2016
French public institutions cnrs, espci and upmc establish a stake in aenitis technologies via fist sa, the cnrs’ technology expl
Read More
July 4, 2015
Aenitis Technologies ​: Winner of 17th Contest in Category I-lab Creation Development
Read More